Barrett's esophagus is characterized by expression of gastric-type mucins (MUC5AC, MUC6) and TFF peptides (TFF1 and TFF2), but the risk of carcinoma development may be indicated by the intestinal-type mucin, MUC2.

Barrett's esophagus is characterized by expression of gastric-type mucins (MUC5AC, MUC6) and TFF peptides (TFF1 and TFF2), but the risk of carcinoma development may be indicated by the intestinal-type mucin, MUC2. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Barrett's esophagus is characterized by expression of gastric-type mucins (MUC5AC, MUC6) and TFF peptides (TFF1 and TFF2), but the risk of carcinoma development may be indicated by the intestinal-type mucin, MUC2. Abstract Text:

Christian Warson,Jeroen H B Van De Bovenkamp,Anita M Korteland-Van Male,Hans A ,Alexandra W C Einerhand,Nadine L E Y Ectors,Jan Dekker,

Barrett's esophagus (BE) consists of metaplastic epithelium of the esophagus, generally diagnosed by mucin histochemistry. We aimed to determine which mucins were expressed in BE, and to relate their expression to BE pathology. Archival biopsies of 4 patient groups were selected, based on standard histochemistry: BE without inflammation, BE with inflammation, ulcerating BE, and BE with dysplasia. Sections were stained by immunohistochemistry for secretory mucins (MUC2, MUC5AC, MUC5B, and MUC6), the proliferation marker Ki-67, and mucin-associated trefoil factor family (TFF) peptides (TFF1, TFF2, and TFF3). MUC5AC and TFF2 were expressed at similar high levels in each clinical group. Intestinal metaplasia (IM), detected both histochemically and by the intestinal mucin MUC2, was lowest in inflamed BE. The expression of the intestinal-type TFF3 did not differ among the groups. Ulcerating BE was distinguished by very low expression of MUC6 and MUC5B, but very high expression of TFF1. Proliferation was not different among the groups. In the total group of BE patients, H. pylori infection of the stomach correlated with decreased TFF2 expression in the BE epithelium. We conclude that BE is best characterized by the specific expression of the gastric-type markers, MUC5AC, MUC6, TFF1, and TFF2. Ulcerating BE constitutes the most distinguished group with respect to mucin and TFF expression. Of the intestinal markers, MUC2 is very specific for IM in BE, whereas TFF3 is not a marker for IM. The low occurrence of IM in inflamed BE suggests that these patients may have the lowest risk of developing carcinoma.

Barrett's esophagus is characterized by expression of gastric-type mucins (MUC5AC, MUC6) and TFF peptides (TFF1 and TFF2), but the risk of carcinoma development may be indicated by the intestinal-type mucin, MUC2. Publishing Authors By Initials

C Warson,JH Van De Bovenkamp,AM Korteland-Van Male,HA ,AW Einerhand,NL Ectors,J Dekker,

For similar proteins: neoplasm proteins: tumor suppressor proteins research abstracts see: proteins: neoplasm proteins: tumor suppressor proteins research

PUBMED ID PMID:

MEDLINE DATE:

Barrett's esophagus is characterized by expression of gastric-type mucins (MUC5AC, MUC6) and TFF peptides (TFF1 and TFF2), but the risk of carcinoma development may be indicated by the intestinal-type mucin, MUC2. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Human pathology

VOLUME: 33

Page Numbers: 660-8

Journal Abbreviation: Hum. Pathol.

ISSN: 0046-8177

DAY: 30

MONTH: Jun

YEAR: 2002

Barrett's esophagus is characterized by expression of gastric-type mucins (MUC5AC, MUC6) and TFF peptides (TFF1 and TFF2), but the risk of carcinoma development may be indicated by the intestinal-type mucin, MUC2. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9421547

Barrett's esophagus is characterized by expression of gastric-type mucins (MUC5AC, MUC6) and TFF peptides (TFF1 and TFF2), but the risk of carcinoma development may be indicated by the intestinal-type mucin, MUC2. Keywords Mesh Terms:

KEYWORDS: Tumor Suppressor Proteins

MESH TERMS: biosynthesis

Chemical & Substance for Abstract: Barrett's esophagus is characterized by expression of gastric-type mucins (MUC5AC, MUC6) and TFF peptides (TFF1 and TFF2), but the risk of carcinoma development may be indicated by the intestinal-type mucin, MUC2. Information

Substance Name: trefoil factor

Registry Number: 146046-78-8

Grant and Affiliation Information for Barrett's esophagus is characterized by expression of gastric-type mucins (MUC5AC, MUC6) and TFF peptides (TFF1 and TFF2), but the risk of carcinoma development may be indicated by the intestinal-type mucin, MUC2.

AFFILIATION: Gastrointestinal Pathology Unit, Catholic University Leuven, Belgium.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Hum Pathol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Barrett's esophagus is characterized by expression of gastric-type mucins MUC5AC, MUC6 and TFF peptides TFF1 and TFF2, but the risk of carcinoma development may be indicated by the intestinal-type mucin, MUC2 Related Publications

• A meta-analysis quantifying transmission parameters of FMDV strain O Taiwan among non-vaccinated and vaccinated pigs.
• An RNA toolbox for single-molecule force spectroscopy studies.
• Barrett's esophagus is characterized by expression of gastric-type mucins (MUC5AC, MUC6) and TFF peptides (TFF1 and TFF2), but the risk of carcinoma development may be indicated by the intestinal-type mucin, MUC2.
• Biosynthesis of human colonic mucin: Muc2 is the prominent secretory mucin.
• Biosynthesis of intestinal mucins: MUC1, MUC2, MUC3 and more.
• Biosynthesis of rat MUC2 in colon and its analogy with human MUC2.
• Cognitive Behavioral Therapy versus Short Psychodynamic Supportive Psychotherapy in the outpatient treatment of depression: a randomized controlled trial.
• Confounding: What it is and how to deal with it.
• Criminalization of medical error: who draws the line?
• Does early response predict outcome in psychotherapy and combined therapy for major depression?
• Effect of intrauterine growth restriction on kidney function at young adult age: the Nord Trøndelag Health (HUNT 2) Study.
• Fate of goblet cells in experimental colitis.
• GC- and AT-rich chromatin domains differ in conformation and histone modification status and are differentially modulated by Rpd3p.
• Gastric-type mucin and TFF-peptide expression in Barrett's oesophagus is disturbed during increased expression of MUC2.
• Gastrointestinal expression and partial cDNA cloning of murine Muc2.
• High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients.
• Interleukin 10-deficient mice exhibit defective colonic Muc2 synthesis before and after induction of colitis by commensal bacteria.
• Long-term effectiveness of exercise therapy in patients with osteoarthritis of the hip or knee: a systematic review.
• Mapping networks of physical interactions between genomic elements using 5C technology.
• Metaplasia of the duodenum shows a Helicobacter pylori-correlated differentiation into gastric-type protein expression.
• Muc2 in ulcerative colitis: a quantitative study.
• Persistence length measurements from stochastic single-microtubule trajectories.
• Reliability studies can be designed more efficiently by using variance components estimates from different sources.
• Selective sparing of goblet cells and paneth cells in the intestine of methotrexate-treated rats.
• Sulphation and secretion of the predominant secretory human colonic mucin MUC2 in ulcerative colitis.
• The nature of the excited state of the reaction center of photosystem II of green plants: A high-resolution fluorescence spectroscopy study.
• The oligomerization of a family of four genetically clustered human gastrointestinal mucins.
• The valuable contribution of observational studies to nephrology.
• Three-dimensional photoacoustic imaging of blood vessels in tissue.
• [Fixation of syndesmotic disruption using bioresorbable screws.]